Typically, a stock with a high score of 8 or 9 would be seen as strong ... La Jolla Pharmaceutical Company (NASDAQ:LJPC) now has an FCF quality score of -2.247226. The free quality score helps estimate the …
NASDAQ
La Jolla Pharmaceutical Company (NASDAQ:LJPC)‘s stock had its “top pick” rating reissued by analysts at Chardan Capital in a research note issued on Tuesday. They currently have a $75.00 price objective on the …
Middle East
The institutional investor acquired 13,746 shares of the biopharmaceutical company’s stock, valued at approximately $327,000. Baker BROS. Advisors LP owned 0.08% of La Jolla Pharmaceutical Company as …
La Jolla
The fund owned 37,900 shares of the biopharmaceutical company’s stock after buying an additional 1,500 shares during the period. Tocqueville Asset Management L.P. owned approximately 0.21% of La Jolla
La Jolla
Stock market analysts watching La Jolla Pharmaceutical Company (LJPC) have recently changed their ratings on the stock. The latest reports which are outstanding on Friday 20th of January state 1 analyst has a …
... statement while doing La Jolla Pharma stock analysis are: Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that LJPC stock has …
Chardan Capital currently has a $75.00 target price on the biopharmaceutical company’s stock. Several other brokerages also recently commented on LJPC. Jefferies Group LLC reaffirmed a buy rating and set a $27.00 …
BNS23d
La Jolla
Below is a chart showing SHLD's trailing twelve month trading history, with the $10 strike highlighted in orange: And La Jolla Pharmaceutical Co. (LJPC) saw options trading volume of 945 contracts, representing …
Juno
LJPC) in a report issued on Monday morning. The brokerage currently has a $27.00 price target on the biopharmaceutical company’s stock. Separately, Zacks Investment Research raised shares of La Jolla
La Jolla
Stock market analysts and brokers have recently amended their target prices on shares of La Jolla Pharmaceutical Company (LJPC). According to the latest research reports released, 1 analyst has issued …